160 related articles for article (PubMed ID: 26211902)
81. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
82. Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.
Xiao Y; Liu Y; Yang S; Zhang B; Wang T; Jiang D; Zhang J; Yu D; Zhang N
Colloids Surf B Biointerfaces; 2016 May; 141():83-92. PubMed ID: 26844644
[TBL] [Abstract][Full Text] [Related]
83. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.
Munir M; Zaman M; Waqar MA; Khan MA; Alvi MN
J Liposome Res; 2024 Jun; 34(2):335-348. PubMed ID: 37840238
[TBL] [Abstract][Full Text] [Related]
84. Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy.
Wang Y; Benzina A; Molin DG; Akker Nv; Gagliardi M; Koole LH
J Biomater Sci Polym Ed; 2015; 26(2):77-91. PubMed ID: 25425276
[TBL] [Abstract][Full Text] [Related]
85. Lipid nanocarriers containing ester prodrugs of flurbiprofen preparation, physical-chemical characterization and biological studies.
Bondìl ML; Craparo EF; Picone P; Giammona G; Di Gesù R; Di Carlo M
J Biomed Nanotechnol; 2013 Feb; 9(2):238-46. PubMed ID: 23627050
[TBL] [Abstract][Full Text] [Related]
86. Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment.
Tunki L; Kulhari H; Vadithe LN; Kuncha M; Bhargava S; Pooja D; Sistla R
Eur J Pharm Sci; 2019 Sep; 137():104978. PubMed ID: 31254645
[TBL] [Abstract][Full Text] [Related]
87. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles.
Zhang H; Zhang FM; Yan SJ
Int J Nanomedicine; 2012; 7():2901-10. PubMed ID: 22787390
[TBL] [Abstract][Full Text] [Related]
88. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles.
Zhao ZB; Long J; Zhao YY; Yang JB; Jiang W; Liu QZ; Yan K; Li L; Wang YC; Lian ZX
Biomater Sci; 2018 Mar; 6(4):893-900. PubMed ID: 29512660
[TBL] [Abstract][Full Text] [Related]
89. Solid lipid nanocarriers in drug delivery: characterization and design.
Mu H; Holm R
Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
[TBL] [Abstract][Full Text] [Related]
90. Improvement of physicochemical properties of nanocolloidal carrier loaded with low water solubility drug for parenteral cancer treatment by Response Surface Methodology.
Izadiyan Z; Basri M; Fard Masoumi HR; Abedi Karjiban R; Salim N; Kalantari K
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():841-849. PubMed ID: 30423770
[TBL] [Abstract][Full Text] [Related]
91. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy.
Wang CF; Mäkilä EM; Kaasalainen MH; Hagström MV; Salonen JJ; Hirvonen JT; Santos HA
Acta Biomater; 2015 Apr; 16():206-14. PubMed ID: 25637067
[TBL] [Abstract][Full Text] [Related]
92. miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.
Li T; Zhang Y; Meng YP; Bo LS; Ke WB
Pharm Res; 2017 Dec; 34(12):2710-2719. PubMed ID: 29181687
[TBL] [Abstract][Full Text] [Related]
93. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells.
Correia A; Shahbazi MA; Mäkilä E; Almeida S; Salonen J; Hirvonen J; Santos HA
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23197-204. PubMed ID: 26440739
[TBL] [Abstract][Full Text] [Related]
94. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles.
Shahbazi MA; Almeida PV; Correia A; Herranz-Blanco B; Shrestha N; Mäkilä E; Salonen J; Hirvonen J; Santos HA
J Control Release; 2017 Mar; 249():111-122. PubMed ID: 28159519
[TBL] [Abstract][Full Text] [Related]
95. Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.
Guo Y; Zhong T; Duan XC; Zhang S; Yao X; Yin YF; Huang D; Ren W; Zhang Q; Zhang X
Drug Deliv; 2017 Nov; 24(1):270-277. PubMed ID: 28165798
[TBL] [Abstract][Full Text] [Related]
96. Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma.
Rahman M; Al-Ghamdi SA; Alharbi KS; Beg S; Sharma K; Anwar F; Al-Abbasi FA; Kumar V
Drug Deliv; 2019 Dec; 26(1):782-793. PubMed ID: 31357897
[TBL] [Abstract][Full Text] [Related]
97. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity.
Nirbhavane P; Sharma G; Singh B; Begum G; Jones MC; Rauz S; Vincent R; Denniston AK; Hill LJ; Katare OP
Colloids Surf B Biointerfaces; 2020 Jun; 190():110902. PubMed ID: 32143010
[TBL] [Abstract][Full Text] [Related]
98. Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery.
Benizri S; Ferey L; Alies B; Mebarek N; Vacher G; Appavoo A; Staedel C; Gaudin K; Barthélémy P
Nanoscale Res Lett; 2018 Jan; 13(1):17. PubMed ID: 29327307
[TBL] [Abstract][Full Text] [Related]
99. Matrix Metalloproteinase Responsive Nanoparticles for Synergistic Treatment of Colorectal Cancer via Simultaneous Anti-Angiogenesis and Chemotherapy.
Shi L; Hu Y; Lin A; Ma C; Zhang C; Su Y; Zhou L; Niu Y; Zhu X
Bioconjug Chem; 2016 Dec; 27(12):2943-2953. PubMed ID: 27998073
[TBL] [Abstract][Full Text] [Related]
100. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study.
Esposito E; Mariani P; Ravani L; Contado C; Volta M; Bido S; Drechsler M; Mazzoni S; Menegatti E; Morari M; Cortesi R
Eur J Pharm Biopharm; 2012 Feb; 80(2):306-14. PubMed ID: 22061262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
